抗体药物在小细胞肺癌中结合:当前的状况和前景
Arjun Syal1, May-Lucie Meyer2,3,4, Kenneth Angelino2,3
1Department of Internal Medicine, Icahn School of Medicine, Mount Sinai Morningside and West, New York, NY 10019, United States.
The oncologist
|October 6, 2025
概括
抗体-药物合物 (ADCs) 通过向癌细胞,对小细胞肺癌 (SCLC) 呈现有前途. 然而,有限的耐用性需要进一步研究,以优化这种侵袭性疾病的治疗方法.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 翻译医学是一种翻译医学.
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有不良预后和有限治疗选择的侵袭性恶性瘤.
- 在SCLC中,初始化疗反应通常被普遍复发所跟随,突出显示出未满足的临床需求.
- 抗体-药物合物 (ADC) 是一种新型治疗类,有可能用于SCLC治疗.
研究的目的:
- 审查目前在小细胞肺癌 (SCLC) 中评估的抗体-药物联合体 (ADC) 的现状.
- 评估ADCs在治疗复发性或耐火性SCLC中的疗效和局限性.
- 确定SCLC中ADC开发的未来方向.
主要方法:
- 在clinicaltrials.gov和pubmed的文献中搜索ADC和SCLC的研究.
- 包括英语语言的来源和相关的参考文献/新闻稿.
- 对评估的抗原,有效载荷和临床结果的分析.
主要成果:
- 针对各种抗原的多个ADC已在复发性/耐药性SCLC中进行了研究.
- 在多个标 (例如DLL3,TROP2,B7-H3,SEZ6) 上,托波酶I抑制剂的有效载荷显示出一致的活性.
- 尽管反应率令人鼓舞,但由于耐药性,异质性和毒性,无进展生存率仍然有限.
结论:
- ADCs在SCLC中显示出有希望的响应率,但缺乏持久的疗效.
- 对有效载荷,链接器和试验设计的优化对于SCLC未来的ADC开发至关重要.
- 需要进一步的研究来确定ADC在SCLC治疗中的持续作用.
更多相关视频
07:36Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
5.8K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
11.0K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K